Physician profile
Andrew Johnson
NPI 1376027870
$1,416.95
in general payments reported to CMS, 2019-2025
18 companies · $451 in 2025
The $451 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $24.72 · 2022: $202 · 2023: $389 · 2024: $349 · 2025: $451.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,171 · Education: $18.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,170.93 |
| Education | $18.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $551.40 | 2022-2025 | Dexcom G6 Transmitter |
| Tandem Diabetes Care, INC. | $191.83 | 2023-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Abbott Laboratories | $131.39 | 2025 | Freestyle Libre 3 |
| Xeris Pharmaceuticals, INC. | $117.88 | 2023 | Gvoke Hypopen |
| Novo Nordisk INC | $96.48 | 2022-2023 | Saxenda, Ozempic, Rybelsus |
| Lilly USA, LLC | $57.84 | 2022-2023 | Trulicity, Mounjaro |
| Insulet Corporation | $48.61 | 2022-2023 | Omnipod |
| Integra Lifesciences Corporation | $24.72 | 2021 | |
| Exelixis INC. | $23.88 | 2022 | |
| Sanofi-Aventis U.S. LLC | $22.30 | 2022 | |
| Radius Health, INC. | $21.59 | 2023 | Tymlos |
| Antares Pharma, INC. | $21.19 | 2023 | Xyosted, Tlando, Nocdurna |
| Medtronic, INC. | $20.59 | 2023 | Minimed 780g |
| Otsuka America Pharmaceutical, INC. | $18.92 | 2025 | Rexulti |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.85 | 2025 | Jardiance |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $18.47 | 2022 | |
| Alvogen INC | $17.18 | 2023 | Teriparatide |
| Amryt Pharma Holdings LTD | $13.83 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.